FASEB LogoFASEB Logo

FASEB ANNOUNCES BIOMEDICAL IMAGE COMPETITION WINNERS
Created by on 05/29/2012

On May 21st, FASEB announced the winners of Bio-Art, its first biomedical image competition. Winning entries were unveiled on FASEB’s web site, displayed during FASEB’s May 16th centennial reception on Capitol Hill, and will be featured in an exhibit on the National Institutes of Health (NIH) campus. The competition drew entries from research institutions and scientific organizations across the country. Entrants, who were required to be either current or former NIH grantees or members of a FASEB constituent society, were asked to submit their most breathtaking laboratory-based images and illustrations depicting the cutting edge of 21st century biomedical research. 

 

Bio-Art submissions spanned the biomedical research space. Among the contest winners were Frank Moutos and Farshid Guilak, of Duke University Medical Center and members the Biomedical Engineering Society, who submitted the following image of a three-dimensionally woven biomaterial scaffold used to accelerate the growth and repair of cartilage.

 

 

 

Another winning entry, shown below, was submitted by American Physiological Society member Li-Hsien Lin of the University of Iowa. Lin’s image is a cross-sectional view of a rat spinal cord and shows the distribution of key enzymes involved in the transmission of respiratory and cardiovascular signals.

 

 
 
Other winning entries included representations of immunohistochemistry, stem cells, evolutionary biology, and other scientific areas. FASEB believes that these and images like them are an important, yet underutilized, resource in the community’s effort to engage and educate the general public and policy makers about biomedical research. To view all ten of the winning entries, please click here. Over a dozen media sources, including MSNBC and New Scientist, reported on the contest and the winning entry.


 

print
 

About Us|Join FASEB|Contact Us|Employment Opportunities|Site Map

Interact, Network, Follow: 

Full Site        Mobile Site